Cellular Biomedicine Group Inc (NASDAQ:CBMG) Investor Alert: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of Cellular Biomedicine Group Inc (NASDAQ:CBMG), filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Cellular Biomedicine Group Inc in connection with certain allegedly false and misleading statements made between June 18, 2014 and April 7, 2015.
View full press release